ARR | Ticker Profile - Titan Protect

ARR

ARMOUR Residential REIT, Inc.

Real Estate · REIT - Mortgage · NYQ

$17.11

Data: 2026-05-28

✗ ETHICAL FAIL

Unknown MOAT

HIGH

Data Confidence: 85.7%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$2.1B

Total market value of the company

Trailing P/E

6.84

Very cheap relative to earnings

Forward P/E

5.57

Based on estimated future earnings — lower means cheaper

Rev Growth

N/A

Year-over-year revenue change

Profit Margin

80.9%

How much profit the company keeps from each dollar of revenue

ROE

11.9%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$18.25

+7% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 4 analysts covering this stock

About ARMOUR Residential REIT, Inc.

ARMOUR Residential REIT, Inc. invests in residential mortgage-backed securities (MBS) in the United States. Its securities portfolio primarily consists of the United States Government-sponsored entity's (GSE) and the Government National Mortgage Administration's issued or guaranteed securities backed by fixed rate, hybrid adjustable rate, and adjustable-rate home loans; and unsecured notes and bonds issued by the GSE and the United States treasuries, as well as money market instruments. The company has elected to be taxed as a real estate investment trust. ARMOUR Residential REIT, Inc. was incorporated in 2008 and is based in Vero Beach, Florida.

https://www.armourreit.com

Country: United States Industry: REIT - Mortgage

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

FAIL

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% N/A

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

DISTRIBUTION

Smart money appears to be selling into strength — caution

Sharpe Ratio

0.625

Good returns relative to risk taken

Kelly Fraction

0.0453

Modest edge detected — smaller position warranted

Calmar Ratio

0.449

Drawdown risk outweighs the returns — higher risk profile

Annual Return

12.6%

Historical annualised return based on price data

Max Drawdown

-28.1%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.37

Moves slightly more than the broader market

52W High

$19.31

11% below the year high

52W Low

$13.98

22% above the year low

Avg Volume

3,146,975

Average daily shares traded — higher means easier to buy and sell

Short Ratio

0.0

Days it would take all short sellers to cover — higher means more crowded

Short % Float

0.0%

Low short interest — limited bearish positioning

Div Yield

1,692.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$2.49

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

790.68

Heavy leverage — higher financial risk if revenues decline

Current Ratio

1.13

Adequate but worth monitoring

Quick Ratio

0.10

Like current ratio but excludes inventory — stricter test

Gross Margin

100.0%

Revenue left after cost of goods — higher means pricing power

Operating Margin

138.8%

Profit from core operations before interest and tax

Free Cash Flow

N/A

Negative — the business is spending more than it generates

Revenue (TTM)

$297M

Total revenue over the last 12 months

Net Income

$228M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$19.00

Target Median

$18.25

Target Low

$18.00

Political Trading Activity

Congressional trading disclosures involving this instrument

Date	Politician	Party	Type	Amount
7 Feb2025	Tim Walberg	Republican	buy	15K–50K
2026-04-24	Ro Khanna	Democrat	Purchase	1K–15K
2026-04-13	Ro Khanna	Democrat	Purchase	1K–15K

Source: Congressional disclosure filings. View all political trades at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go